Head to head

Agnes RF vs Exion Fractional RF (2026)

Compare purchase costs, running costs and the evidence behind each device.

Read the comparison overview

Purchase cost: Catalog new-price ranges: Agnes RF, $30k–$50k; Exion Fractional RF, $30k–$45k. Check the source notes and request current quotes.
Practice fit: Both are listed under RF microneedling. Check each model’s US regulatory status and labeled indications for your intended use.

Device A

RF Microneedling

View full device profile →

Device B

RF Microneedling

View full device profile →

Price comparison

Price comparison: Agnes RF vs BTL Aesthetics Exion Fractional RF
Attribute	Agnes RF	BTL Aesthetics Exion Fractional RF
New price range	$30k–$50kSource not documented	$30k–$45kSource not documented
Used asking range	$15k–$25kSource not documented	$14k–$25kSource not documented
Payback calculator	View ROI calculator	View ROI calculator
Next step

New price range

Agnes RF: $30k–$50kSource not documented
BTL Aesthetics Exion Fractional RF: $30k–$45kSource not documented

Used asking range

Agnes RF: $15k–$25kSource not documented
BTL Aesthetics Exion Fractional RF: $14k–$25kSource not documented

Payback calculator

Agnes RF: View ROI calculator
BTL Aesthetics Exion Fractional RF: View ROI calculator

Next step

Agnes RF

BTL Aesthetics Exion Fractional RF

Consumable economics

Consumable economics: Agnes RF vs BTL Aesthetics Exion Fractional RF
Attribute	Agnes RF	BTL Aesthetics Exion Fractional RF
Consumable cost / lock-in	Supply pricing is not documented with a dated source yet. Request an itemized supply quote.	—
Service cost	Not published	Not published

Consumable cost / lock-in

Agnes RF: Supply pricing is not documented with a dated source yet. Request an itemized supply quote.
BTL Aesthetics Exion Fractional RF: —

Service cost

Agnes RF: Not published
BTL Aesthetics Exion Fractional RF: Not published

FDA clearance

FDA clearance: Agnes RF vs BTL Aesthetics Exion Fractional RF
Attribute	Agnes RF	BTL Aesthetics Exion Fractional RF
FDA status & indication	FDA ClearedK192728, K203013, K223805, K250217 Read FDA indication wording “AGNES is indicated for use in dermatological and general surgical procedures for electrocoagulation and hemostasis.”	FDA ClearedK211639, K222556, K233604 Read FDA indication wording “The BTL-785W device has the following indications for use: The BTL-785W with BTL-785-1 applicator is intended to provide heating for the purpose of elevating tissue temperature for selected medical conditions such as temporary relief of pain, muscle spasms, and increase in local circulation. The BTL-785-1-4 massage device is intended to provide a temporary reduction in the appearance of cellulite. The BTL-785W with BTL-785-2 applicator is indicated to provide heating for the purpose of elevating tissue temperature for selected medical conditions such as temporary relief of pain, muscle spasms, and increase in local circulation. The BTL-785W with BTL-785-3 applicator is intended to provide heating for the purpose of elevating tissue temperature for selected medical conditions such as temporary relief of pain, muscle spasms, and increase in local circulation. The BTL-785W with BTL-785-4 applicator used with tips BTL-785-4-1, BTL-785-4-2, BTL-785-4-5 and BTL-785-4-6 is indicated for use in dermatological and general surgical procedures for electrocoagulation and hemostasis. The Applicator BTL-785-4 of BTL-785W device used with tips BTL-785-4-3, BTL-785-4-4, BTL-785-4-7 and BTL-785-4-8 is intended for dermatological procedures requiring fractional treatment of the skin. At higher energy levels greater than 62 mJ/pin, use of the BTL-785-4 applicator is limited to Skin Types IIV. The BTL-785W with BTL-785-7 hands-free applicator used with BTL-785-7-1, BTL-785-7-2, BTL-785- 7-3, BTL-785-7-4, BTL-785-7-5 and BTL-785-7-6 single-use electrodes is intended to provide heating for the purpose of elevating tissue temperature for selected medical conditions such as temporary relief of pain, muscle spasms, and increase in local circulation.”

FDA status & indication

Agnes RF: FDA ClearedK192728, K203013, K223805, K250217
Read FDA indication wording
“AGNES is indicated for use in dermatological and general surgical procedures for electrocoagulation and hemostasis.”
BTL Aesthetics Exion Fractional RF: FDA ClearedK211639, K222556, K233604
Read FDA indication wording
“The BTL-785W device has the following indications for use: The BTL-785W with BTL-785-1 applicator is intended to provide heating for the purpose of elevating tissue temperature for selected medical conditions such as temporary relief of pain, muscle spasms, and increase in local circulation. The BTL-785-1-4 massage device is intended to provide a temporary reduction in the appearance of cellulite. The BTL-785W with BTL-785-2 applicator is indicated to provide heating for the purpose of elevating tissue temperature for selected medical conditions such as temporary relief of pain, muscle spasms, and increase in local circulation. The BTL-785W with BTL-785-3 applicator is intended to provide heating for the purpose of elevating tissue temperature for selected medical conditions such as temporary relief of pain, muscle spasms, and increase in local circulation. The BTL-785W with BTL-785-4 applicator used with tips BTL-785-4-1, BTL-785-4-2, BTL-785-4-5 and BTL-785-4-6 is indicated for use in dermatological and general surgical procedures for electrocoagulation and hemostasis. The Applicator BTL-785-4 of BTL-785W device used with tips BTL-785-4-3, BTL-785-4-4, BTL-785-4-7 and BTL-785-4-8 is intended for dermatological procedures requiring fractional treatment of the skin. At higher energy levels greater than 62 mJ/pin, use of the BTL-785-4 applicator is limited to Skin Types IIV. The BTL-785W with BTL-785-7 hands-free applicator used with BTL-785-7-1, BTL-785-7-2, BTL-785- 7-3, BTL-785-7-4, BTL-785-7-5 and BTL-785-7-6 single-use electrodes is intended to provide heating for the purpose of elevating tissue temperature for selected medical conditions such as temporary relief of pain, muscle spasms, and increase in local circulation.”

Which chains run each

Which chains run each: Agnes RF vs BTL Aesthetics Exion Fractional RF
Attribute	Agnes RF	BTL Aesthetics Exion Fractional RF
Chain adoption	0 recorded pairings	0 recorded pairings
Chains using it	—	—
Approved reviews	0	0

Chain adoption

Agnes RF: 0 recorded pairings
BTL Aesthetics Exion Fractional RF: 0 recorded pairings

Chains using it

Agnes RF: —
BTL Aesthetics Exion Fractional RF: —

Approved reviews

Agnes RF: 0
BTL Aesthetics Exion Fractional RF: 0

Specs and platform

Specs and platform: Agnes RF vs BTL Aesthetics Exion Fractional RF
Attribute	Agnes RF	BTL Aesthetics Exion Fractional RF
Manufacturer	Agnes Medical	BTL Aesthetics
Built by (OEM)	Agnes Medical Co., Ltd.	BTL Industries
Category	RF Microneedling	RF Microneedling
Technology	Precision single/tri-needle RF (eyes, acne)	Monopolar RF microneedling + AI needle-free energy (RF Microneedling)
Launch year	2019	2022
Status	Current	Current
Manufacturer source record	No linked source on file.	No linked source on file.

Manufacturer

Agnes RF: Agnes Medical
BTL Aesthetics Exion Fractional RF: BTL Aesthetics

Built by (OEM)

Agnes RF: Agnes Medical Co., Ltd.
BTL Aesthetics Exion Fractional RF: BTL Industries

Current alternatives

Current catalog models in related categories. Confirm availability and configuration with the supplier.

InMode Morpheus8

RF Microneedling

New: $40k–$120k depending on configuration (standalone Morpheus8 console $40k–$60k; InMode multi-handpiece platform bundle $80k–$120k)

Cartessa VirtueRF

RF Microneedling

New: —

Jeisys Intracel Pro

RF Microneedling

New: $50k

Rohrer Aesthetics Pixel8-RF

RF Microneedling

New: $67,495 (Rohrer-advertised price)

Get a free recommendation Browse by goal

Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Price figures are references, not current offers. Check each device’s source notes. Not medical, legal or regulatory advice.